Jaco A C van Bruggen (J A C van Bruggen)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Cell Cycle Arrest

Staphylococcus Aureus

Chronic Lymphocytic Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jaco A C van Bruggen, Fleur S Peters, Morris Mes, Joanne M Rietveld, Elisa Cerretani, Gaspard Cretenet, Roel van Kampen, Aldo Jongejan, Perry D Moerland, Jan Joseph Melenhorst, Gerritje J W van der Windt, Eric Eldering, Arnon P Kater
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells. Blood advances 8 (17) (2024)
Jaco A C van Bruggen, Fleur S Peters, Morris Mes, Joanne M Rietveld, Elisa Cerretani, Gaspard Cretenet, Roel van Kampen, Aldo Jongejan, Perry D Moerland, Jan Joseph Melenhorst, Gerritje J W van der Windt, Eric Eldering, Arnon P Kater
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells. Blood advances 8 (17) (2024)
Jaco A C van Bruggen, G J W van der Windt, M Hoogendoorn, J Dubois, Arnon P Kater, Fleur S Peters
Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells. Blood advances 6 (14) (2022)